Vertex Pharmaceuticals Inc
XMUN:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
I
|
Industria de Diseno Textil SA
XMUN:IXD1
|
ES |
|
Orange SA
PAR:ORA
|
FR |
|
D
|
Darden Restaurants Inc
XBER:DDN
|
US |
|
S
|
Schneider Electric SE
DUS:SND
|
FR |
|
Neste Oyj
F:NEF
|
FI |
|
T
|
TAG Immobilien AG
F:TEG
|
DE |
|
S
|
Sofina SA
F:8FS
|
BE |
|
H
|
H & M Hennes & Mauritz AB
XMUN:HMSB
|
SE |
|
Siemens AG
F:SIEB
|
DE |
|
A
|
Agricultural Bank of China Ltd
XMUN:EK7
|
CN |
|
T
|
Tencent Holdings Ltd
F:NNN1
|
CN |
|
E
|
Equifax Inc
DUS:EFX
|
US |
|
C
|
Comcast Corp
XHAM:CTP2
|
US |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 477.04 EUR with a low forecast of 283.49 EUR and a high forecast of 572.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
477.04
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 477.04 EUR with a low forecast of 283.49 EUR and a high forecast of 572.46 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
